Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

返回 Agenda

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

Session Chair(s)

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

Regulatory Affairs: The IND, NDA, and Post-Marketing

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

Session Chair(s)

Elliott Berger, PhD, MS

获得信息并保持参与